The pathophysiology of acute pancreatitis involves activation of the pancreatic proenzymes. Levels of the trypsinogen activation peptide in urine in acute pancreatitis has been shown to correlate with the severity of disease. However, this peptide is unstable in urine and, because of its low molecular mass, difficult to measure. Procarboxypeptidase B has a larger activation peptide which could be more suitable for analysis in serum and urine
Acute Pancreatitis (AP) is an inflammatory condition of the pancreas, presenting initially as severe...
Background: The activation peptide released from procarboxypeptidase B, CAPAP, is a marker of the ac...
Acute pancreatitis is a common digestive disease which is usually diagnosed when there is acute abdo...
Summary Background Early prediction of severity is important in the management of patients with acut...
Background: Carboxypeptidase B from the pancreatic gland may exist in three different molecular and ...
Objective To assess the sensitivity and specificity of the serum carboxypeptidase B activation pepti...
Recent developments in the treatment of acute pancreatitis have focused on the importance of early d...
Approximately 10—20 % of patients with acute pancreatitis (AP) develop a severe disease with high mo...
1 Approximately 10–20 % of patients with acute pancreatitis (AP) develop a severe disease with high ...
There is a wide range in the reported annual incidence of acute pancreatitis (AP). A minority of the...
BACKGROUND/AIMS: The pathophysiology of acute pancreatitis (AP) may be studied using markers of prot...
Background: Severity prediction is difficult early in the course of acute pancreatitis. Markers of p...
Background: Trypsinogen activation peptide (TAP) may be an early marker of severe pancreatitis. Pre...
Pancreatic enzymes, neutrophils, free radicals and cytokines are involved in the pathophysiology of ...
Introduction: The concentration of carboxypeptidase B activation peptide (CAPAP) is proposed to be a...
Acute Pancreatitis (AP) is an inflammatory condition of the pancreas, presenting initially as severe...
Background: The activation peptide released from procarboxypeptidase B, CAPAP, is a marker of the ac...
Acute pancreatitis is a common digestive disease which is usually diagnosed when there is acute abdo...
Summary Background Early prediction of severity is important in the management of patients with acut...
Background: Carboxypeptidase B from the pancreatic gland may exist in three different molecular and ...
Objective To assess the sensitivity and specificity of the serum carboxypeptidase B activation pepti...
Recent developments in the treatment of acute pancreatitis have focused on the importance of early d...
Approximately 10—20 % of patients with acute pancreatitis (AP) develop a severe disease with high mo...
1 Approximately 10–20 % of patients with acute pancreatitis (AP) develop a severe disease with high ...
There is a wide range in the reported annual incidence of acute pancreatitis (AP). A minority of the...
BACKGROUND/AIMS: The pathophysiology of acute pancreatitis (AP) may be studied using markers of prot...
Background: Severity prediction is difficult early in the course of acute pancreatitis. Markers of p...
Background: Trypsinogen activation peptide (TAP) may be an early marker of severe pancreatitis. Pre...
Pancreatic enzymes, neutrophils, free radicals and cytokines are involved in the pathophysiology of ...
Introduction: The concentration of carboxypeptidase B activation peptide (CAPAP) is proposed to be a...
Acute Pancreatitis (AP) is an inflammatory condition of the pancreas, presenting initially as severe...
Background: The activation peptide released from procarboxypeptidase B, CAPAP, is a marker of the ac...
Acute pancreatitis is a common digestive disease which is usually diagnosed when there is acute abdo...